MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, the company offers personal lines of property and casualty insurance, including private passenger automobile, homeowners', and personal excess liability insurance. Further, it provides fixed and variable annuities, and pension products; accident and health products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
IPO Year: 2000
Exchange: NYSE
Website: metlife.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/23/2025 | $97.00 | Market Perform | BMO Capital Markets |
| 10/9/2024 | $97.00 | Buy | TD Cowen |
| 9/5/2024 | $91.00 | Overweight | Barclays |
| 1/8/2024 | $80.00 | Neutral → Buy | Goldman |
| 11/17/2023 | $71.00 | Overweight | Barclays |
| 10/5/2023 | $71.00 | Hold | Deutsche Bank |
| 9/14/2023 | $58.00 → $72.00 | Hold → Buy | Jefferies |
| 1/9/2023 | $80.00 → $78.00 | Buy → Neutral | Goldman |
| 12/9/2022 | $86.00 → $82.00 | Buy → Hold | Jefferies |
| 9/22/2022 | Mkt Perform | Raymond James |
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
4 - METLIFE INC (0001099219) (Issuer)
Fastest customizable press release news feed in the world
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
MetLife, Inc. (NYSE:MET) today announced that Michel Khalaf, president and chief executive officer, and John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, will participate in a fireside chat at the 2025 Keefe, Bruyette & Woods Annual Insurance Conference on Wednesday, Sept. 3, 2025, from 10:05 a.m. to 10:45 a.m. (ET). A live audio webcast of the presentation will be available at https://event.summitcast.com/view/K8Qj6Ho6wvLLfFK2h5DE7w/n8bgBuwQnmybd6vjVT2Jmi. Those who want to listen should go to the website at least 15 minutes prior to the presentation to download and install any necessary software. A replay of the presentation
LOS ANGELES, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The 2025 Pet Innovation Awards today announced that MetLife Pet Insurance (MetLife) has been selected as "Pet Insurance of the Year" in the 7th Annual Awards Program. The Pet Innovation Awards is an independent recognition platform highlighting the most innovative companies, services, and products in the highly competitive Pet Care industry. Pet owners are investing more in preventive health measures and MetLife offers the protection needed for all stages of a pet's life, including an optional preventive care coverage add-on. This add-on features coverage for flea and tick control, spay/neuter, heartworm prevention, teeth cleaning, vaccinat
MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results. Earnings Return Per Share on Equity (ROE) 2Q 2025 2Q 2025 Net Income $1.03 ROE 11.7% Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i
MetLife, Inc. (NYSE:MET) today announced that Adrienne O'Neill will join the company as Executive Vice President and Chief Accounting Officer, effective Sept. 2, 2025. She will report to John McCallion, Executive Vice President and Chief Financial Officer, and head of MetLife Investment Management. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250730103304/en/Adrienne O'Neill "We're excited to bring on board Adrienne's deep expertise in accounting, financial planning, and financial reporting, as well as her proven and broad leadership experience across an array of finance functions," said McCallion. "She will be a critical part
MetLife, Inc. (NYSE:MET) today announced that it will hold its second quarter 2025 earnings conference call and audio webcast on Thursday, August 7, 2025, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its second quarter 2025 earnings news release and Second Quarter 2025 Financial Supplement on Wednesday, August 6, 2025, after the market closes. The news release and Second Quarter 2025 Financial Supplement will also be available on the MetLife Investor Relations webpage (https://investor.metlife.com). The conference call will be available live via the internet. To listen to the conference call, click the following link to register (https://events.q4inc.com/attendee/683094
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a third quarter 2025 common stock dividend of $0.5675 per share. The dividend will be payable on Sept. 9, 2025, to shareholders of record as of Aug. 5, 2025. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and
MetLife, Inc., General Atlantic, and Chariot Reinsurance, Ltd. (Chariot Re), an independent Bermuda-based Class E life and annuity reinsurance company, today announced the completion of Chariot Re's initial reinsurance transaction with a subsidiary of MetLife. Chariot Re will reinsure approximately $10 billion of liabilities, including structured settlement annuity contracts and group annuity contracts associated with pension risk transfers originated by MetLife. Chariot Re provides a unique platform positioned to reshape the life and annuity reinsurance market. The company is co-sponsored by MetLife and General Atlantic with backing from lead investor Chubb and other investors. MetLife I
Sprout.ai, an insurance automation specialist, today announced it has partnered with MetLife, a leading global insurer, to drive claims automation and deliver improved claims experiences. The collaboration, which spans multiple territories across the US, Asia and LATAM regions, is aimed at improving accuracy, speed and the overall customer experience. Sprout.ai's purpose-built AI technology seamlessly integrates into insurers' existing systems, enabling automated claims decisions that are both swift and fair. By combining Sprout.ai's advanced capabilities with MetLife's human expertise, it ensures that AI serves as a powerful complement - amplifying human judgment, empathy, and experience
8-K - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
8-K - METLIFE INC (0001099219) (Filer)
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
BMO Capital Markets initiated coverage of MetLife with a rating of Market Perform and set a new price target of $97.00
TD Cowen initiated coverage of MetLife with a rating of Buy and set a new price target of $97.00
Barclays initiated coverage of MetLife with a rating of Overweight and set a new price target of $91.00
Goldman upgraded MetLife from Neutral to Buy and set a new price target of $80.00
Barclays resumed coverage of MetLife with a rating of Overweight and set a new price target of $71.00
Deutsche Bank initiated coverage of MetLife with a rating of Hold and set a new price target of $71.00
Jefferies upgraded MetLife from Hold to Buy and set a new price target of $72.00 from $58.00 previously
Goldman downgraded MetLife from Buy to Neutral and set a new price target of $78.00 from $80.00 previously
Jefferies downgraded MetLife from Buy to Hold and set a new price target of $82.00 from $86.00 previously
Raymond James initiated coverage of MetLife with a rating of Mkt Perform
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
4 - METLIFE INC (0001099219) (Issuer)
Live Leadership Updates
Acquisition includes high yield, strategic fixed income and small-cap equity teams MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has reached a definitive agreement to acquire three investment teams and assets managed by Mesirow, an independent, employee-owned financial services firm. MIM is acquiring the high yield and bank loan, strategic fixed income and small-cap equity teams and certain related investment products. Under the terms of the transaction, about $6 billion of assets managed by the acquired teams will transfer to MIM, subject to customary approvals and consents. The acquisition is consi
MetLife Investment Management (MIM), the institutional asset management business of MetLife, Inc. (NYSE:MET), today announced that it has appointed Kerry O'Brien as global head of Insurance Asset Management and Liability Solutions. She will be responsible for the execution of investment strategies for the MetLife general account, helping drive growth in MIM's third-party insurance client channel as well as working with teams to drive liability solutions across other client segments. O'Brien will lead a team with an insurance investing heritage of nearly 150 years and an active role in managing MetLife's $414.1 billion general account as well as assets for third-party insurance clients. Sh
Combining the medical and ancillary strengths of two leading global carriers into a single solution -- Globaline™ MetLife and GeoBlue, the international solution for the Blue Cross® Blue Shield® companies, announced today they will offer a full suite of expatriate benefit products in a best-in-class single solution, Globaline™. Globaline™ brings together health coverage and services from GeoBlue – including medical, dental, vision, prescription, wellness, international employee assistance program and political and natural disaster assistance – and life, accidental death & dismemberment and long term disability coverage from MetLife Worldwide Benefits, including value-added services, such
MetLife's John Wilson takes over for Kramden founder, who headed the board for two decades As a part of MetLife's, Inc. (NYSE:MET) global strategy to increase diversity in Science, Technology, Engineering and Math (STEM), the company today announced that John Wilson was named chair of the Board of Kramden Institute, a North Carolina non-profit that provides technology and training to bridge the digital divide. Wilson takes over the chair position from the organization's founder, Mark Dibner, who has overseen Kramden's growth for the last 20 years. "We are blessed to have a board of directors passionate about technology and social impact," said Cyndy Yu-Robinson, Kramden Executive Direct
Sofía Belmar to take new role with Latin America regional team and be succeeded by Mario Valdes, who currently oversees six operations in Central and Eastern Europe These changes reinforce MetLife's commitment to cross-region talent development and succession planning After six years of successfully leading MetLife's operation in Mexico – the company's third-largest global operation – Sofía Belmar-Berumen will be taking a new regional role as Head of Business Development and Transformation, Latin America. Belmar's leadership and business acumen have been critical for MetLife Mexico to become the leading player in the local insurance industry. A prominent thought leader, she is the first
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (“MetLife”), announced today that James Reid has been named CEO of Versant Health, a managed vision care company and wholly owned subsidiary of MetLife. The appointment is effective April 1. “James brings extensive and varied experience in the Group Benefits market to Versant Health,” said Todd Katz, chairman of the Versant Health Board of Directors and executive vice president, Group Benefits at MetLife. “His dedication to delivering for customers, focus on building talent and background in both sales and general management makes him ideally suited to lead Versant to new levels of growth.” Reid brings more than 30 years of experience in
NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that its board of directors has declared a first quarter 2021 common stock dividend of $0.46 per share. The dividend will be payable on March 15, 2021, to shareholders of record as of Feb. 5, 2021. About MetLife MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help its individual and institutional customers navigate their changing world. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United
Live finance-specific insights
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35263005 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Semi-annual dividend of $29.375 per share on the company's 5.875% fixed-to-floating rate non-cumulative preferred stock, Series D, with a liquidation preference of $1,000 per share. Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest
MetLife, Inc. (NYSE:MET) today announced its second quarter 2025 results. Earnings Return Per Share on Equity (ROE) 2Q 2025 2Q 2025 Net Income $1.03 ROE 11.7% Adjusted Earnings $2.02 Adjusted ROE 14.6% Net income was $698 million. Adjusted earnings declined to $1.4 billion, due to less favorable underwriting and lower investment margins, partially offset by volume growth and favorable expense margins. Premiums, fees and other revenues (PFOs) were $12.7 billion. Adjusted
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and chief financial officer, and head of MetLife Investment Management, has provided a second quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250806874930/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and i
MetLife, Inc. (NYSE:MET) today announced that it will hold its second quarter 2025 earnings conference call and audio webcast on Thursday, August 7, 2025, from 9-10 a.m. (ET). The call will follow MetLife's issuance of its second quarter 2025 earnings news release and Second Quarter 2025 Financial Supplement on Wednesday, August 6, 2025, after the market closes. The news release and Second Quarter 2025 Financial Supplement will also be available on the MetLife Investor Relations webpage (https://investor.metlife.com). The conference call will be available live via the internet. To listen to the conference call, click the following link to register (https://events.q4inc.com/attendee/683094
MetLife, Inc. (NYSE:MET) today announced that its board of directors has declared a third quarter 2025 common stock dividend of $0.5675 per share. The dividend will be payable on Sept. 9, 2025, to shareholders of record as of Aug. 5, 2025. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Asia, Latin America, Europe and
MetLife, Inc. (NYSE:MET) today announced that it has declared the following preferred stock dividends: Quarterly dividend of $0.35141735 per share on the company's floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE:MET). Quarterly dividend of $351.5625 per share on the company's 5.625% non-cumulative preferred stock, Series E, with a liquidation preference of $25,000 per share, represented by depositary shares each representing 1/1,000th interest in a share of the preferred stock, holders of which will receive $0.3515625 per depositary share (NYSE:MET). Quarterly dividend of $296.875 per share on the company's 4.75% non-cumul
MetLife, Inc. (NYSE:MET) today announced its first quarter 2025 results. Earnings Per Share Return on Equity (ROE) 1Q 2025 1Q 2025 Net Income $ 1.28 ROE 14.9 % Adjusted Earnings $ 1.96 Adjusted ROE 14.4 % Net income increased 10% to $879 million. Premiums, fees and other revenues (PFOs) increased 14% to $13.6 billion. Adjusted earnings rose 1% to $1.3 billion. Higher life underwriting margins, volume growth and variable investment income were partially offset by unfavorable foreign currency impacts and lower recurring interest margins. Book value increased 2% to $35.16 per share. A
MetLife, Inc. (NYSE:MET) today announced that John McCallion, executive vice president and CFO, and head of MetLife Investment Management, has provided a first quarter 2025 financial update video. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250430216095/en/ The video can be viewed on the company's website at https://www.metlife.com/about-us/newsroom/#video. About MetLife MetLife, Inc. (NYSE:MET), through its subsidiaries and affiliates ("MetLife"), is one of the world's leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers b
MetLife, Inc. (NYSE:MET) today announced that its board of directors has approved a new $3 billion authorization for the company to repurchase its common stock. The new authorization is incremental to the approximately $360 million remaining under the company's prior authorization announced in May 2024. "This new share repurchase authorization and the 4.1% increase in our common stock dividend that we announced earlier this month reflect MetLife's financial strength and all-weather performance," said MetLife President and Chief Executive Officer Michel Khalaf. "Altogether, these actions illustrate our commitment to providing an attractive total return for our shareholders as part of our Ne
Agreement with a subsidiary of Talcott Financial Group to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves Transaction demonstrates MetLife's focused execution across New Frontier strategic priorities MetLife, Inc. (NYSE:MET) today announced it has entered into an agreement with Talcott Resolution Life Insurance Company (Talcott), a life insurance and annuities subsidiary of Talcott Financial Group, to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves. The combined value of the transaction is expected to be approximately $250 million consisting of both ceding commission and capital released over time. The planne
This live feed shows all institutional transactions in real time.
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13G/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)
SC 13D/A - METLIFE INC (0001099219) (Subject)